EE168 Avoidable Costs in Patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated with Darolutamide
Abstract
Authors
M Roa C. López-Cabra L Torres Mejía F Salcedo R Camerano Vivanco FA Chaparro Mercado J Fernandez De la Rosa F Gómez Zakzuk NR Alvis N. Alvis-Guzman R Marrugo